Vaccines for COVID-19 are critical tools for helping bring the pandemic under control when combined with effective testing and existing prevention measures. With several promising vaccine candidates in the pipeline, some under review for approval and the Pfizer/BioNTech, Moderna and Oxford-AstraZeneca vaccines approved for use by a number of stringent national regulatory bodies, the race for a safe and effective vaccine has entered into a new phase. Read more